This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04544/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04544/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04544/identifier/pubchem-substance/
n9http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB04544/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04544
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB04544 n11:DB04544
dcterms:title
1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide
adms:identifier
n7:DB04544 n10:46509200 n12:CR6 n13:46937004
n3:IUPAC-Name
n4:271B63D0-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B63D6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B63D5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B63D2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B63D3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B63D4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B63CE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B63CC-363D-11E5-9242-09173F13E4C5 n4:271B63CF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B63CD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B63DC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B63DD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B63D7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B63D8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B63DA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B63D9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B63DB-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B63E2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B63E4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B63E5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B63E1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B63E0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B63E3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B63D1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B63DE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B63DF-363D-11E5-9242-09173F13E4C5